Skip to main content
. Author manuscript; available in PMC: 2008 Oct 7.
Published in final edited form as: Carcinogenesis. 2008 May 21;29(6):1184–1191. doi: 10.1093/carcin/bgn085

Table II.

Interaction of genotypes with cigarette smoking in non-Hispanic white participants

Genotype Smoke (pack-years) Male
Female
Cases/controls, n OR (95% CI)a Pinteraction Cases/controls, n OR (95% CI)a Pinteraction
CYP1A2*1F 0.805 <0.001
 AC/CC Never 60/62 1.0 55/79 1.0
 AA Never 78/86 0.99 (0.61–1.60) 60/62 1.35 (0.80–2.25)
 AC/CC ≤20 50/43 1.11 (0.64–1.94) 31/27 1.51 (0.78–2.91)
 AA ≤20 42/47 0.94 (0.53–1.64) 35/24 2.31 (1.21–4.42)
 AC/CC >20 74/44 1.75 (1.03–2.97) 38/22 2.24 (1.15–4.38)
 AA >20 81/72 1.06 (0.64–1.73) 45/16 4.36 (2.15–8.84)
Ptrend 0.430 <0.001
SULT1A1 0.023 <0.001
 GG Never 59/52 1.0 43/53 1.0
 GA/AA Never 79/96 0.76 (0.47–1.25) 72/89 0.97 (0.57–1.65)
 GG ≤20 27/33 0.73 (0.38–1.41) 19/21 1.00 (0.46–2.19)
 GA/AA ≤20 60/53 0.94 (0.54–1.62) 43/30 1.91 (1.00–3.62)
 GG >20 49/48 0.84 (0.48–1.47) 38/19 2.45 (1.18–5.08)
 GA/AA >20 97/69 1.21 (0.72–2.01) 44/18 2.96 (1.45–6.06)
Ptrend 0.330 <0.001
NAT1 0.408 0.012
 Non*10 Never 88/101 1.0 70/96 1.0
 *10 Never 50/47 1.22 (0.74–2.02) 45/46 1.34 (0.78–2.29)
 Non*10 ≤20 62/56 1.18 (0.73–1.89) 45/38 1.64 (0.93–2.87)
 *10 ≤20 25/30 0.92 (0.49–1.73) 17/13 1.98 (0.89–4.44)
 Non*10 >20 97/82 1.24 (0.81–1.90) 55/27 2.71 (1.50–4.89)
 *10 >20 49/35 1.55 (0.91–2.66) 27/10 4.01 (1.73–9.29)
Ptrend 0.300 <0.001
NAT2 0.021 0.002
 R/I Never 62/53 1.0 56/65 1.0
 Slow Never 76/95 0.65 (0.40–1.06) 59/77 0.81 (0.48–1.36)
 R/I ≤20 39/38 0.80 (0.44–1.45) 23/21 1.47 (0.72–3.03)
 Slow ≤20 48/48 0.77 (0.44–1.37) 39/30 1.34 (0.71–2.53)
 R/I >20 58/51 0.87 (0.51–1.51) 39/16 2.71 (1.30–5.65)
 Slow >20 88/66 1.03 (0.62–1.71) 43/21 2.27 (1.16–4.46)
Ptrend 0.622 0.001

R/I = rapid/intermediate.

a

OR was adjusted for age, family history of cancer, history of diabetes and alcohol consumption.